InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Monday, 05/20/2019 11:52:06 AM

Monday, May 20, 2019 11:52:06 AM

Post# of 345952
Did Memorial Sloan Kettering ever clear up the troubles with MDs there utilizing PS Targeting data elsewhere?

Patents for PS Targeting worth Billions and Ronin Capital Management John Springs Stafford the new puppeteer

No wonder why Optera still tries to remain cloaked and maybe Berkeley Lights can shine a light on what has been going on ...

https://www.wbur.org/hereandnow/2019/03/01/immunotherapy-patent-battle
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News